sodium valproate
PolandDrugs containing this active substance
-
The medicine is used in the treatment of epilepsy (various types of seizures) and manic episodes (abnormally elevated mood and increased activity) occurring in bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC: N03AG01
Manufacturer: Orion Corporation
-
The medicine is used in the treatment of epilepsy (various types of seizures) and manic episodes in bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage sodium valproate 500 mg ATC: N03AG01
Manufacturer: Orion Corporation
-
The medicinal product is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage sodium valproate 300 mg ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The medicine is used in adults and children to treat various forms of epilepsy, including generalized seizures and partial seizures.
Form: syrup
Active substance Dosage sodium valproate 50 mg/ml valproic acid 4.338 g sodium chloride 0.04 g ATC: N03AG01
Manufacturer: G.L. Pharma GmbH
-
The drug is used as an anticonvulsant in various types of epilepsy. It is used in status epilepticus when other intravenous medications are ineffective, in cluster seizures, and prophylactically before neurosurgical procedures of the head. It may also be used when a patient cannot take medication orally.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg/4 ml ATC: N03AG01
Manufacturer: Sanofi Belgium
-
The medicine is used in adults and children for the treatment of various types of epileptic seizures (both generalized and partial).
Form: syrup
Active substance Dosage sodium valproate 5.764 g ATC: N03AG01
Manufacturer: Sanofi Winthrop Industrie Unither Liquid Manufacturing
-
The medicine is used to counteract seizures in various types of epilepsy. It is used, among other things, in status epilepticus when other medicines are ineffective, in cluster seizures, and prophylactically before neurosurgical procedures of the head.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to counteract seizures in various types of epilepsy. It is used, among other things, in status epilepticus when other medicines are ineffective, in cluster seizures, and prophylactically before neurosurgical procedures of the head.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to counteract seizures in various types of epilepsy. It is used, among others, in status epilepticus when other drugs are ineffective, in cluster seizures, and prophylactically before neurosurgical procedures of the head.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
Manufacturer: Sanofi s.r.o.
-
The medicine is used to counteract seizures in various types of epilepsy. It is used, among others, in status epilepticus when other drugs are ineffective, in cluster seizures, and prophylactically before neurosurgical procedures of the head.
Form: solution for injection, powder and solvent for preparation of
Active substance Dosage sodium valproate 400 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to treat epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 200 mg valproic acid 87 mg ATC: N03AG01
Manufacturer: Sanofi Aventis S.A. Sanofi Winthrop Industry
-
The medicine is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
It is used in the treatment of epilepsy (various forms) and mania occurring in bipolar disorder.
Form: tablets, film-coated, prolonged release
Active substance Dosage sodium valproate 333 mg valproic acid 145 mg ATC: N03AG01
Manufacturer: Sanofi-aventis Monoprósopi S.A.
-
The medicine is used to treat epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 66.66 mg valproic acid 29.03 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to treat epilepsy (different types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 666.6 mg valproic acid 290.27 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used in the treatment of epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 166.76 mg valproic acid 72.61 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicine is used to treat epilepsy (various types of seizures) and mania occurring in bipolar disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 333.3 mg valproic acid 145.14 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicinal product is used in the treatment of epilepsy (various types of seizures, including myoclonic, tonic-clonic, atonic, as well as West syndrome and Lennox-Gastaut syndrome) and in the treatment of mania occurring in bipolar affective disorder.
Form: granules, prolonged release
Active substance Dosage sodium valproate 500.06 mg valproic acid 217.75 mg ATC: N03AG01
Manufacturer: Sanofi Winthrop Industry
-
The medicinal product is used in the treatment of epilepsy (in its various forms) and in the treatment of mania occurring in the course of a condition called bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH
-
The medicinal product is used in the treatment of epilepsy (in its various forms) and in the treatment of mania occurring in bipolar disorder.
Form: tablets, prolonged release
Active substance Dosage valproic acid No input provided sodium valproate No input provided ATC: N03AG01
Manufacturer: HEXAL A/S Lek Pharmaceuticals d.d. LEK S.A. Salutas Pharma GmbH